Reviva Pharmaceuticals Holdings, Inc. expected to post a loss of 32 cents a share - Earnings Preview

Reviva Pharmaceuticals Holdings

12/05/2023 12:10

* Reviva Pharmaceuticals Holdings, Inc.  RVPH.OQ 
 RVPH.O  is
expected to show no change in quarterly revenue when it reports 
results on May 15 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Reviva
Pharmaceuticals
Holdings, Inc. is for a loss of 32 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Reviva
Pharmaceuticals Holdings, Inc. is $16​, above​ its last closing
price of $7.92. ​​​

This summary was machine generated May 12 at 11:10 GMT.  All
figures in US dollars  unless otherwise stated